1. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer
   JIANCHUN WU et al, 2015, Oncology Reports CrossRef
2. Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential
   Lu Gan et al, 2018, Biomarker Research CrossRef
3. Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus–associated gastric carcinoma
   Min Dong et al, 2016, Human Pathology CrossRef
4. H19: A Vital Long Noncoding RNA in the Treatment of Diabetes and Diabetic Complications
   Leiqi Zhu et al, 2022, Current Pharmaceutical Design CrossRef
5. Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis
   Tao Jiang et al, 2016, Oncotarget CrossRef
6. Pharmacoepigenetics of EZH2 Inhibitors
   Cameron Lindsay et al, 2019, Pharmacoepigenetics CrossRef
7. Adaptation to Hypoxia May Promote Therapeutic Resistance to Androgen Receptor Inhibition in Triple-Negative Breast Cancer
   Nikita Jinna et al, 2022, International Journal of Molecular Sciences CrossRef
8. Clinicopathologic significance of protein lysine methyltransferases in cancer
   Theodore Vougiouklakis et al, 2020, Clinical Epigenetics CrossRef
9. Tumor-suppressive functions of protein lysine methyltransferases
   Nur Aziz et al, 2023, Experimental & Molecular Medicine CrossRef
10. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2
    Anthos Christofides et al, 2016, Oncotarget CrossRef
11. Clinical and prognostic relevance of EZH2 in breast cancer: A meta-analysis
    Xu Wang et al, 2015, Biomedicine & Pharmacotherapy CrossRef
12. Hypoxia-driven epigenetic regulation in cancer progression: A focus on histone methylation and its modifying enzymes
    Iljin Kim et al, 2020, Cancer Letters CrossRef
13. Autologous blood transfusion augments impaired wound healing in diabetic mice by enhancing lncRNA H19 expression via the HIF-1α signaling pathway
    Jian-Rong Guo et al, 2018, Cell Communication and Signaling CrossRef
14. EZH2 Expression and Survival for ER+/tamoxifen Treated Breast Cancer Patients with rs2302427 C>G: A Novel Prognostic and Risk Predictive Biomarker
    Nisha Gautam et al, 2023, Archives of Medical Research CrossRef
15. The synthetic histone-binding regulator protein PcTF activates interferon genes in breast cancer cells
    Kimberly C. Olney et al, 2018, BMC Systems Biology CrossRef